Efficacy of influenza vaccine in the elderly: Reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes

International Journal of Clinical and Laboratory Research

Volumn 30, Issue 1, 2000, Pages 1-4

  Deguchi, Y ^a   Takasugi, Y ^b  

^a Osaka Prefectural Government   (Japan)

^b Osaka Prefectural Government   (Japan)

Author keywords

Elderly; Influenza vaccination; Nursing home residents

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

AGED; ARTICLE; BLOOD; COHORT ANALYSIS; EPIDEMIC; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; ISOLATION AND PURIFICATION; JAPAN; MALE; NURSING HOME; SAFETY; STATISTICS;

AGED; ANTIBODIES, VIRAL; COHORT STUDIES; DISEASE OUTBREAKS; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; MALE; NURSING HOMES; SAFETY;

INFLUENZA VIRUS; INFLUENZAVIRUS A;

EID: 0033919967     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990070025     Document Type: Article

References (16)

1. Monto AS. Influenza: quantifying morbidity and mortality. Am J Med 1987; 82[Suppl 6A]:20.
2. Fedson DS, Hirota Y, Shin, HK, et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine. 1997; 15:1506.
3. US Preventive Serious Task Force. Adult immunizations. In: Guide to clinical preventive services, 2nd edn. Baltimore: Williams and Wilkins; 1996: 791.
4. Williams GO. Vaccines in older patients:combating the risk of mortality. Geriatrics 1980; 35:55.
5. Massab HF, DeBorde DC. Characterization of an influenza A host range mutant. Virology 1983; 130:342.
6. Kilbourne ED. Influenza. New York: Plenum; 1987: 265.
7. Dowdle WR, Mostow SR, Coleman MT, Kaye HS, Schoenbaum SC. Inactivated influenza vaccines, 2. Laboratory indices of protection. Postgrad Med J 1973; 49:159.
8. The 1995-96 WHO influenza reagent kit for the identification of influenza isolates. Appendix A. Atlanta: Centers for Diseases Control and Prevention, 1995.
9. Howells CH, Vesselinova-Jenkins CK, Evans AD, James J. Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet 1975; I:381.
10. Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987; 77:712.
11. Gross PA, Quinnan GV, Rodstein M, LaMontagne JR, Kaslow RA, Saah AJ, et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Ann Intern Med 1988; 148:562.
12. Mantel N, Haenszel W. Statistical aspects of the analysis of data from respective studies of disease. J Natl Cancer Inst 1959; 22:719.
13. Arritage P, Berry G. Statistical methods in medical research, 3rd edn. Oxford: Blackwell Scientific Publications, 1994.
14. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza in elderly persons. Am Coll Physicians 1995; 123:518.
15. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 1990; 264:1139.
16. Perez-Tirse J, Gross PA. Review of cost-benefit analyses of influenza vaccine. Pharmacoeconomics 1992; 2:198.